Last updated on February 2018

Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma

Brief description of study

In this study for elderly myeloma patients lenalidomide plus low-dose dexamethasone until progression is being compared with age-adjusted tandem high-dose melphalan 140 mg/m augmented by induction with 3 cycles of lenalidomide plus low-dose dexamethasone before transplantation and lenalidomide maintenance after transplantation.

Clinical Study Identifier: NCT01090089

Find a site near you

Start Over